InMed: A Text Book Lesson in how Biotechs Drive Share Value Through Innovation.

InMed announces results of a study co-sponsored with the University of British Columbia. The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens. This study further validates the Company’s capacity to conduct a wide spectrum of drug development activities

Tweed and DNA Genetics renew and expand their partnership

Tweed Inc., wholly-owned subsidiary of Canopy Growth Corporation and DNA Holding LLC are proud to announce the renewal and expansion of their partnership through to October 2022. Together they are committed to bringing the best possible cannabis to Canada.